Latest filing published 16 Jul 2020 for Poseida Therapeutics, Inc..
No signal scores available.
Novartis Pharma AG has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Idenix Pharmaceuticals Inc and Poseida Therapeutics, Inc. The record holds 2 filings, for trades running from 5 August 2014 to 14 July 2020.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 16 July 2020 with a transaction in Poseida Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations